Metastatic Sertoli cell carcinoma of the testis

Metastatic Sertoti cell tumor is a very rare and deadly disease accounting for approximately 1% of all testicular carcinomas. With fewer than 30 cases reported in the literature, there has not been a uniform treatment regimen with good results. Retroperitoneal lymph node dissection, chemotherapy, an...

Full description

Saved in:
Bibliographic Details
Published inJournal of Osteopathic Medicine (Online) Vol. 96; no. 10; p. 612
Main Authors Finkelstein, Leonard H., Mene, Matthew P., Manfrey, Samuel J., Belkoff, Laurence H.
Format Journal Article
LanguageEnglish
Published United States American Osteopathic Association 01.10.1996
Subjects
Adult
Chemotherapy, Adjuvant
Combined Modality Therapy
Humans
Male
Neoplasm Metastasis
Orchiectomy
Sertoli Cell Tumor - diagnosis
Sertoli Cell Tumor - therapy
Testicular Neoplasms - diagnosis
Testicular Neoplasms - therapy
Tomography, X-Ray Computed
Online AccessGet full text

Cover

More Information
Summary:Metastatic Sertoti cell tumor is a very rare and deadly disease accounting for approximately 1% of all testicular carcinomas. With fewer than 30 cases reported in the literature, there has not been a uniform treatment regimen with good results. Retroperitoneal lymph node dissection, chemotherapy, and radiation therapy in combination appear to offer the best outcome. This report describes the occurrence of this rare tumor in a 38-year-old man 2 years after left orchiectomy.
ISSN:0098-6151
2702-3648
2702-3648
DOI:10.7556/jaoa.1996.96.10.612